Comparative retrospective evaluation of efficacy of rituximab therapy with dexamethasone cyclophosphamide pulse therapy in patients of pemphigus vulgaris at a tertiary care hospital
Background: Popular treatment modalities for pemphigus vulgaris are dexamethasone cyclophosphamide pulse (DCP) therapy and rituximab. However, no previous studies are available which have compared the efficacy of the two modalities. Aim: This study aims to study the response of pemphigus vulgaris to...
Main Authors: | Preema Sinha, Bhavni Oberoi, Arun Kumar Yadav, Vikas Pathania, Durga Madhab Tripathy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Medical Journal of Dr. D.Y. Patil Vidyapeeth |
Subjects: | |
Online Access: | http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2020;volume=13;issue=2;spage=120;epage=124;aulast=Sinha |
Similar Items
-
A comparative study to evaluate the efficacy and cost of rituximab versus dexamethasone cyclophosphamide pulse in patients of pemphigus vulgaris
by: Sudip Das, et al.
Published: (2021-01-01) -
Dexamethasone cyclophosphamid pulse therapy in pemphigus-appraisal of its outcome
by: Prabhash Kulhari, et al.
Published: (2012-01-01) -
Outcome of pulse therapy in pemphigus: A 10-year study
by: Sirisha Varala, et al.
Published: (2018-01-01) -
Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
by: Dae San Yoo, MD, et al.
Published: (2020-02-01) -
Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01)